Filter
802
Text search:
Multidrug
resistant
tuberculosis
Featured
96
188
Language
Document type
494
119
95
33
24
19
7
7
3
1
Countries / Regions
52
37
30
22
19
17
15
12
11
11
11
10
9
9
8
8
8
7
7
7
7
7
7
6
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
221
89
30
20
13
9
6
Toolboxes
410
84
53
19
16
12
12
11
11
9
8
7
6
6
6
6
5
4
4
2
1
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on
...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-
...
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
(updated December 2014).
First report of a demonstration project
Annual Report: 2015-2016
(updated December 2014).
(updated December 2014).
Advocacy report March 2011
303100 03/2011 E 1,000
Policy and Manual
